Advertisement

Topics

Teva Plunged More But Mylan Still The Better Pick

16:05 EDT 7 Aug 2017 | Topix

Since late 2013, the share prices of the two leading generics names, Teva Pharmaceutical Industry and Mylan , have moved largely in tandem with each other. This is despite several company-specific issues and well-reported controversies plaguing each of the two.

Original Article: Teva Plunged More But Mylan Still The Better Pick

NEXT ARTICLE

More From BioPortfolio on "Teva Plunged More But Mylan Still The Better Pick"

Quick Search
Advertisement